• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低氧张力产生的含多能生长因子血清的抗衰老作用。

The Anti-Aging Effects of Low Oxygen Tension Generated Multipotent Growth Factor Containing Serum.

作者信息

Draelos Zoe Diana, Karnik Jwala, Naughton Gail

出版信息

J Drugs Dermatol. 2017 Jan 1;16(1):30-34.

PMID:28095530
Abstract

Growth factors are a new category of ingredient found in modern cosmeceutical formulations. One novel method of obtaining cosmeceutical growth factors is the use of a bioreactor to culture neonatal broblasts on dextran microcarrier beads for 8 weeks under low oxygen tension (1-5%) mimicking embryonic conditions and eliminating the need for fetal bovine serum constituents in the final cosmetic material. This research evaluated the ingredient in a moisturizing vehicle on 40 females to determine its efficacy in improving overall facial skin appearance, as well as skin brightness, evenness, firmness, pore size, radiance, fine lines, coarse wrinkles, and blotchiness/ dispigmentation. Statistically significant improvement was seen in 90 days in skin hydration through corneometry, as well in global investigator and subject assessments. J Drugs Dermatol. 2017;16(1):30-34..

摘要

生长因子是现代药妆配方中发现的一类新成分。一种获取药妆用生长因子的新方法是使用生物反应器,在模拟胚胎条件的低氧张力(1 - 5%)下,将新生成纤维细胞在葡聚糖微载体珠上培养8周,并在最终的化妆品原料中无需胎牛血清成分。这项研究在40名女性的保湿载体中评估了该成分,以确定其在改善整体面部皮肤外观以及皮肤亮度、均匀度、紧致度、毛孔大小、光泽度、细纹、粗皱纹和斑点/色素沉着方面的功效。通过角质层水合测量法,在90天内皮肤水合作用有统计学意义的改善,在全球研究者和受试者评估中也是如此。《皮肤药物学杂志》。2017年;16(1):30 - 34。

相似文献

1
The Anti-Aging Effects of Low Oxygen Tension Generated Multipotent Growth Factor Containing Serum.低氧张力产生的含多能生长因子血清的抗衰老作用。
J Drugs Dermatol. 2017 Jan 1;16(1):30-34.
2
The Effect of a Combination of Recombinant EGF Cosmetic Serum and a Crosslinked Hyaluronic Acid Serum as Compared to a Fibroblast-Conditioned Media Serum on the Appearance of Aging Skin.重组表皮生长因子美容血清与交联透明质酸血清联合使用相较于成纤维细胞条件培养基血清对衰老皮肤外观的影响。
J Drugs Dermatol. 2016 Jun 1;15(6):738-41.
3
Anti-aging proof of concept study: results and summary.抗衰老概念验证研究:结果与总结
J Drugs Dermatol. 2014 Sep;13(9):1074-81.
4
The Role of a Natural Mollusk Egg-Derived Ingredient in Facial Appearance.一种天然软体动物卵源性成分在面部外观中的作用。
J Drugs Dermatol. 2017 Jul 1;16(7):678-681.
5
An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin.一项旨在改善面部老化皮肤外观的肽治疗血清及辅助方案的开放标签临床试验。
J Drugs Dermatol. 2016 Sep 1;15(9):1100-6.
6
Human Stem Cell-Derived Skin Progenitors Produce Alpha 2-HS Glycoprotein (Fetuin): A Revolutionary Cosmetic Ingredient.人干细胞衍生的皮肤祖细胞产生α2-HS糖蛋白(胎球蛋白):一种革命性的化妆品成分。
J Drugs Dermatol. 2016 May 1;15(5):583-98.
7
Efficacy and Tolerability of a Novel Topical Treatment for Neck: A Randomized, Double-blind, Regimen-Controlled Study.一种新型颈部局部治疗的疗效和耐受性:一项随机、双盲、对照研究。
J Drugs Dermatol. 2021 Feb 1;20(2):184-191. doi: 10.36849/JDD.5819.
8
Clinical Evidence of Dermal and Epidermal Restructuring from a Biologically Active Growth Factor Serum for Skin Rejuvenation.一种用于皮肤年轻化的生物活性生长因子血清实现真皮和表皮重塑的临床证据。
J Drugs Dermatol. 2019 Mar 1;18(3):290-295.
9
In vitro and clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti-aging and antioxidant activities.SIG1273的体外和临床评估:一种具有广泛抗老化和抗氧化活性的化妆品功能成分。
J Cosmet Dermatol. 2016 Jun;15(2):150-7. doi: 10.1111/jocd.12206. Epub 2016 Jan 11.
10
Efficacy and Tolerability of a Skin Brightening/Anti-Aging Cosmeceutical Containing Retinol 0.5%, Niacinamide, Hexylresorcinol, and Resveratrol.一款含有0.5%视黄醇、烟酰胺、己基间苯二酚和白藜芦醇的亮肤/抗衰化妆品的功效与耐受性
J Drugs Dermatol. 2016 Jul 1;15(7):863-8.

引用本文的文献

1
Epidermal Growth Factor in Aesthetics and Regenerative Medicine: Systematic Review.表皮生长因子在美学与再生医学中的应用:系统评价
J Cutan Aesthet Surg. 2021 Apr-Jun;14(2):137-146. doi: 10.4103/JCAS.JCAS_25_20.